The Glenmede Trust Company, N.A.

Latest statistics and disclosures from GLENMEDE TRUST CO NA's latest quarterly 13F-HR filing:

• Top 5 stock holdings are JNJ, XOM, AAPL, MRK, MSFT, and represent 10.95% of GLENMEDE TRUST CO NA's stock portfolio.
• Added to shares of these 10 stocks: JNJ (+$832.29M), XOM (+$185.20M), Dfa Us Large Cap Equity (+$111.03M), CTSH (+$89.41M), Aqr Style Premia Alt - I mut (+$85.05M), MRK (+$80.51M), IART (+$47.26M), Aqr Risk Parity Fund -i (+$46.81M), CTXS (+$46.62M), Nielsen Hldgs Plc Shs Eur stock (+$45.82M).
• Started 392 new stock positions in Corridor Communications Corp, Oramed Pharm, Pandora A /s, Etfs Precious Metals Basket phys pm bskt, MRLN, Tiaa-cref International Equity Index Fd, Health Sciences Grp, VRTS, LABL, NBIX.
• Reduced shares in these 10 stocks: ATVI (-$65.26M), PEP (-$57.46M), Tessera Hldg (-$52.02M), WOOF (-$49.03M), DG (-$47.33M), SPG (-$43.93M), , CDNS (-$40.15M), Steelpath Mlp Alpha Fund op end (-$39.83M), CSX (-$37.27M).
• Sold out of its positions in Put On Abbv 2/17/17 @ 55, Aberdeen Emerging Markets, ACAD, Ally Financial, American Funds Global Balanced Fund Class A m, ABCB, Amplify Snack Brands, Anglo American, AU, Associates First Cap Corp Resi cs.
• GLENMEDE TRUST CO NA was a net buyer of stock by $1.68B.
• GLENMEDE TRUST CO NA has $20.92B in assets under management (AUM), growing by 13.85%.